No Data
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
Indivior to Release Q1 2025 Financial Results and Host Webcast
Indivior PLC Updates Share Capital and Voting Rights
Is Indivior PLC (INDV) the Best Stock to Buy According to Howard Marks' Oaktree Capital Management?
Indivior PLC Announces Change in Major Holdings
Indivior Insiders Placed Bullish Bets Worth US$1.42m